Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications
Overview
Affiliations
Over the past decades, non-viral DNA and RNA delivery systems have been intensively studied as an alternative to viral vectors. Despite the most significant advantage over viruses, such as the lack of immunogenicity and cytotoxicity, the widespread use of non-viral carriers in clinical practice is still limited due to the insufficient efficacy associated with the difficulties of overcoming extracellular and intracellular barriers. Overcoming barriers by non-viral carriers is facilitated by their chemical structure, surface charge, as well as developed modifications. Currently, there are many different forms of non-viral carriers for various applications. This review aimed to summarize recent developments based on the essential requirements for non-viral carriers for gene therapy.
Martinez Junior A, Ruiz T, Vilamaior P, Tiera V, Taboga S, Tiera M Drug Deliv Transl Res. 2025; .
PMID: 39907973 DOI: 10.1007/s13346-025-01800-4.
T14diLys/DOPE Liposomes: An Innovative Option for siRNA-Based Gene Knockdown?.
Meinhard S, Erdmann F, Lucas H, Krabbes M, Kruger S, Wolk C Pharmaceutics. 2025; 17(1).
PMID: 39861674 PMC: 11769127. DOI: 10.3390/pharmaceutics17010025.
Advances in RNA-Based Therapeutics: Challenges and Innovations in RNA Delivery Systems.
Liu Y, Ou Y, Hou L Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852137 PMC: 11763986. DOI: 10.3390/cimb47010022.
Amphiphilic dynamic covalent polymer vectors of siRNA.
Coll J, Trousselier P, Pawar S, Bessin Y, Lichon L, Leblond Chain J Chem Sci. 2025; 16(5):2413-2419.
PMID: 39790989 PMC: 11707677. DOI: 10.1039/d4sc07668k.
Lee J, Kim Y, Kim E, Jang M, Park S Biomater Res. 2024; 28:0087.
PMID: 39319107 PMC: 11420687. DOI: 10.34133/bmr.0087.